Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Iopamidol
Drug ID BADD_D01181
Description Iopamidol is a contrast agent developed by Bracco with nonionic, low-osmolar properties.
Indications and Usage Not Available
Marketing Status approved
ATC Code V08AB04
DrugBank ID DB08947
KEGG ID D01797
MeSH ID D007479
PubChem ID 65492
TTD Drug ID D0O2HQ
NDC Product Code 68225-077; 0270-1412; 68225-078; 68225-100; 0270-1315; 0270-1317; 0270-1411; 70436-126; 62331-006; 0270-1316; 68225-076; 0270-1314; 70436-124; 57876-222
UNII JR13W81H44
Synonyms Iopamidol | Jopamidol | Gastromiro | Iopamidol, (+-)-Isomer | Iopamidol, (R)-Isomer | Iopamidol, Sodium Salt, (S)-Isomer | Iopamiro | Isovue 370 | Niopam | Solutrast | Solutrast 370 | Solutrast Gastro | SQ 13,396 | B-15,000 | B 15,000 | B15,000 | B-15000 | B 15000 | B15000 | Isovue
Chemical Information
Molecular Formula C17H22I3N3O8
CAS Registry Number 60166-93-0
SMILES CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Diarrhoea07.02.01.001--
Discomfort08.01.08.0030.022763%Not Available
Disorientation17.02.05.015; 19.13.01.002--Not Available
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.0030.132309%
Dry throat22.12.03.005; 07.06.01.005--Not Available
Dysarthria19.19.03.001; 17.02.08.001--
Dysgeusia17.02.07.003; 07.14.03.001--
Dyskinesia17.01.02.006--
Dyspepsia07.01.02.001--
Dysphagia07.01.06.0030.059041%
Dysphonia22.12.03.006; 19.19.03.002; 17.02.08.0040.062598%
Dyspnoea02.11.05.003; 22.02.01.0040.271020%
Echolalia19.11.03.004; 17.02.08.013--Not Available
Electrocardiogram abnormal13.14.05.001--Not Available
Electrocardiogram ST segment depression13.14.05.005--Not Available
Electroencephalogram abnormal13.07.03.001--Not Available
Erythema23.03.06.0010.193484%Not Available
Erythema multiforme23.03.01.003; 10.01.03.0150.007113%
Extrasystoles02.03.02.003--Not Available
Extravasation08.01.03.0080.275288%Not Available
Eye irritation06.04.05.0030.034856%Not Available
Eye swelling06.08.03.0030.041969%Not Available
Eyelid oedema10.01.05.001; 23.04.01.003; 06.04.04.0040.010670%Not Available
Face oedema23.04.01.004; 10.01.05.002; 08.01.07.003--
Fatigue08.01.01.002--
Feeling abnormal08.01.09.0140.038412%Not Available
Feeling cold08.01.09.0080.015649%Not Available
Feeling hot08.01.09.0090.041969%Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.0250.104567%
Guillain-Barre syndrome10.04.10.005; 17.09.01.001; 11.07.01.001--
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 10 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene